| Application no. and date | 07840190.8 (espacenet) (Federated) (European Patent Register), 20070521 | | Patent/reg. no. and date | DK/EP 2026801, 20131106 | | Publication date | 20090225 | | Priority no. and date | US 747974 P, 20060523, US 803049 P, 20060524, US 835658 P, 20060804 | | EP pub. no. and date |
EP 2026801 20090225 | | Effective date | | | Applicant/owner | Novartis AG, Corporate Intellectuel Property
CH-4002 Basel, CH | | Applicant ref. no. | NGC/GP/148090 | | Inventor | NICK, Hanspeter, In den Gärten 8b
CH-4202 Duggingen, CH,
ROJKJAER, Lisa, 84 Clover Lane
Princeton, New Jersey 08540, US,
BODNER, Janet Ellen, 14 Mine Mount Road
Bernardsville, New Jersey 07924, US,
MARKS, Peter Wayne, 145 Rimmon Road
Woodbridge, Connecticut 06525, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4196 (2006.01) , A61P 3/12 (2006.01) , A61P 43/00 (2006.01) , A61P 7/00 (2006.01) | | Title | Deferasirox til behandling af arvelig hæmochromatose | | Int. application no. | US2007069319 | | Int. publication no. | WO2008005624 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
